tirzepatide and letrozole TrimRX Letrozole Tablets | CareFirst Specialty

This FDA-approved dual GLP-1/GIP receptor agonist has revolutionized weight loss treatments, offering significant results by targeting the body's natural hormones that regulate appetite and insulin function

Insulin resistance accelerates this pathway, so improving insulin sensitivity (which tirzepatide does through weight reduction and GIP receptor activation) slows triglyceride production directly

"Tirzepatide Once Weekly for the Treatment of Obesity." NEJM

(Off-label drug use means prescribing a drug for a purpose other than what its been approved for by the FDA.) To learn more, see the Ozempic off-label use for weight loss section